American Chemical Society
|Agreement labeling||Read & Publish Program|
|Has the agreement been fully disclosed and published?||Yes|
|Agreement period||01/01/2023 – 12/31/2023|
|Consortia / Institution||Bibsam Consortium|
Approximate range of annual corresponding author publications
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
Transformative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions partly converted to OA publishing fees|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|The agreement has a limit on published articles per year. Additional articles/tokens can be purchased with discount.|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||Yes|
|OA LICENSE||CC-BY mandatory|
||Original research articles
Not for eBooks. Articles that are additions or corrections or editorials are also not eligible.
What is the approximate share of access related costs of the overall agreement?
|Comments on access costs||We have applied an internal price redistribution: 90% publishing fee and 10% reading fee|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||Partly (e.g. to core journals only)|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|